Trial
NCT00325650
Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Prediabetic State
Intervention
Rimonabant
Why stopped
Company decision taken in light of demands by certain national health authorities
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-18